Raelipskie Partnership’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.26M	Sell	18,325 -300	-2%	-$20.7K	0.58%	44
2025 Q1	$1.29M	Buy	18,625 +3,007	+19%	+$209K	0.66%	39
2024 Q4	$1.34M	Buy	15,618 +3,000	+24%	+$258K	0.67%	38
2024 Q3	$1.5M	Hold	12,618	–	–	0.73%	32
2024 Q2	$1.8M	Buy	+12,618	New	+$1.8M	0.96%	25